Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

5′ Flanking Variants of Resistin Are Associated With Obesity

Engert, James C., Vohl, Marie-Claude, Williams, Scott M., Lepage, Pierre, Loredo-Osti, J C., Faith, Janet, Doré, Carole, Renaud, Yannick, Burtt, Noël P., Villeneuve, Amélie, Hirschhorn, Joel N., Altshuler, David, Groop, Leif C., Després, Jean-Pierre, Gaudet, Daniel, Hudson, Thomas J.·2002·Diabetes

Abstract

Diabetes and obesity have long been known to be related. The recently characterized adipocyte hormone resistin (also called FIZZ3/ADSF) has been implicated as a molecular link between impaired glucose tolerance (IGT) and obesity in mice. A search for sequence variants at the human resistin locus identified nine single-nucleotide polymorphisms (SNPs) but no coding variants. An investigation into the association of these SNPs with diabetes and obesity revealed two 5′ flanking variants (g.-537 and g.-420), in strong linkage disequilibrium, that are associated with BMI. In nondiabetic individuals from the Quebec City area and the Saguenay-Lac-St-Jean region of Quebec, the g.-537 mutation (allelic frequency = 0.04) was significantly associated with an increase in BMI (P = 0.03 and P = 0.01, respectively). When the data from these two populations were combined and adjusted for age and sex, both the g.-537 (odds ratio [OR] 2.72, 95% CI 1.28–5.81) and the g.-420 variants (1.58, 1.06–2.35) were associated with an increased risk for a BMI ≥30 kg/m2. In contrast, in case/control and family-based study populations from Scandinavia, we saw no effect on BMI with either of these promoter variants. No association was seen with diabetes in any of the population samples.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diabetes.51.5.1629

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 169

Metadata

Authors
Engert, J. C., Vohl, M.-C., Williams, S. M., Lepage, P., Loredo-Osti, J. C., Faith, J., Doré, C., Renaud, Y., Burtt, N. P., Villeneuve, A., Hirschhorn, J. N., Altshuler, D., Groop, L. C., Després, J.-P., Gaudet, D., & Hudson, T. J.
Venue
Diabetes
Published
2002-05-01
Volume
51
Issue
5
Pages
1629-1634
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2155788236
Cited by
169
References
2
FWCI
14.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 5′ Flanking Variants of Resistin Are Associated With Obesity. https://app.cochat.ai/papers/10.2337/diabetes.51.5.1629
The paper
Engert, J. C., Vohl, M.-C., Williams, S. M., Lepage, P., Loredo-Osti, J. C., Faith, J., Doré, C., Renaud, Y., Burtt, N. P., Villeneuve, A., Hirschhorn, J. N., Altshuler, D., Groop, L. C., Després, J.-P., Gaudet, D., & Hudson, T. J. (2002). 5′ Flanking Variants of Resistin Are Associated With Obesity. Diabetes. https://doi.org/10.2337/diabetes.51.5.1629

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.